: Developing treatments like antisense oligonucleotides (ASOs) to reverse abnormal splicing caused by AIRE mutations.
: Investigating how AIRE-dependent development of specific "early life" Tregs protects tissues from attack, which could lead to new immunotherapies for T1D and other autoimmune conditions. daniella aire
Editorial: The Role of Aire, microRNAs and Cell ... - PMC - NIH daniella aire